Resectable Carcinoma
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer (NCT05802407) | Peking Union Medical College Hospital | 2023-02-01 |
| Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT) (NCT04736485) | Centre Francois Baclesse | 2021-06-28 |
| Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy (NCT04554771) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-01-27 |
Track Resectable Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.